Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.

Employees

1,290

Sector

Specialty Chemicals

Calendar

08/09/2024 - H.C. Wainwright Global Investment Conference

Related indices

Russell 2000

More about the company

Quotes

Date	Price	Change	Volume
09/09/24	167.16 $	-0.87%	52,056
06/09/24	168.63 $	-1.90%	130,426
05/09/24	171.90 $	-0.37%	79,112
04/09/24	172.54 $	+0.43%	59,071
03/09/24	171.80 $	-2.95%	104,196

Delayed Quote Nasdaq, September 09, 2024 at 08:02 pm

More quotes

Income Statement and Estimates

More financial data

Ratings

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

168.63USD

Average target price

188.67USD

Spread / Average Target

+11.88%

Consensus

Profit revisions

Estimate revisions

Quarterly earnings, Rate of surprise

Company calendar

Real-time Estimate Cboe BZX Other stock markets 20:29:11 09/09/2024 BST			5-day change	1st Jan Change
167.66 ^USD	-0.58%		-2.70%	+12.38%

08-05	Balchem Insider Sold Shares Worth $1,395,412, According to a Recent SEC Filing	MT
07-26	Transcript : Balchem Corporation, Q2 2024 Earnings Call, Jul 26, 2024

Capitalization	5.47B 418B	P/E ratio 2024 *	42.5x	P/E ratio 2025 *	36.6x
Enterprise value	5.6B 428B	EV / Sales 2024 *	5.83x	EV / Sales 2025 *	5.29x
Free-Float	99.53%	Yield 2024 *	-	Yield 2025 *	-

Balchem Insider Sold Shares Worth $1,395,412, According to a Recent SEC Filing	08-05	MT
Transcript : Balchem Corporation, Q2 2024 Earnings Call, Jul 26, 2024	07-26
Balchem's Q2 Earnings, Net Sales Rise	07-26	MT
Earnings Flash (BCPC) BALCHEM CORPORATION Posts Q2 Revenue $234.1M, vs. Street Est of $239.7M	07-26	MT
Earnings Flash (BCPC) BALCHEM CORPORATION Posts Q2 EPS $1.09, vs. Street Est of $1.04	07-26	MT
Balchem Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	07-26	CI
Balchem Insider Sold Shares Worth $297,935, According to a Recent SEC Filing	05-13	MT
HC Wainwright Adjusts Balchem Price Target to $170 From $167, Maintains Buy Rating	05-06	MT
Tranche Update on Balchem Corporation's Equity Buyback Plan announced on August 6, 1999.	05-03	CI
Transcript : Balchem Corporation, Q1 2024 Earnings Call, May 03, 2024	05-03
Balchem Q1 Adjusted Net Earnings, Net Sales Advance	05-03	MT
Earnings Flash (BCPC) BALCHEM CORPORATION Reports Q1 Revenue $239.7M	05-03	MT
Earnings Flash (BCPC) BALCHEM CORPORATION Posts Q1 EPS $1.03	05-03	MT

HC Wainwright Adjusts Balchem Price Target to $170 From $167, Maintains Buy Rating	05-06	MT
HC Wainwright Cuts Price Target on Balchem to $135 From $165, Maintains Buy Rating	30/10/23	MT
HC Wainwright Adjusts Price Target on Balchem to $165 From $150, Maintains Buy Rating	31/07/23	MT
HC Wainwright Adjusts Price Target on Balchem to $150 From $140, Keeps Buy Rating	05/06/23	MT
HC Wainwright Adjusts Price Target on Balchem to $140 From $152, Keeps Buy Rating	27/02/23	MT

Balchem Corporation Share Price

Equities

BCPC

US0576652004

Specialty Chemicals

Valuation: Balchem Corporation

Chart: Balchem Corporation

Latest news: Balchem Corporation

Last Transcript: Balchem Corporation

Analysts' recommendations: Balchem Corporation

Press Releases: Balchem Corporation

News in other languages: Balchem Corporation

Quotes and Performance

Course Extremes

Managers and Directors: Balchem Corporation

ETFs: Balchem Corporation

Other Specialty Chemicals

Financials

Company Profile

Quotes

Income Statement and Estimates

Ratings

Analysts' Consensus

Quarterly earnings, Rate of surprise

Balchem Corporation to Present at the HC Wainwright & Co. 26th Annual Global Investment Conference on September 9, 2024	08-26	AQ
Balchem Corporation to Present at the HC Wainwright & Co. 26th Annual Global Investment Conference on September 9, 2024	08-23	GL
Blachem: Q2 Earnings Snapshot	07-26	AQ
Balchem Corporation Reports Second Quarter 2024 Financial Results	07-26	GL
Balchem Corporation Announces Quarterly Conference Call for Second Quarter Financial Results on July 26, 2024	07-15	AQ

Een grafisch perspectief op de markten	08/07/23
Grafici in prospettiva: uno sguardo ai mercati	07/07/23
Grafiken im Fokus: Ein Blick auf die Märkte	07/07/23
Gráficos en perspectiva: Una mirada a los mercados	07/07/23
Les graphiques en perspective : un regard sur les marchés	07/07/23

1 day	-0.87%
1 week	-2.70%
Current month	-5.58%
1 month	+2.14%
3 months	+10.68%
6 months	+7.13%
Current year	+12.38%

Director	Title	Age	Since
Theodore Harris CEO	Chief Executive Officer	59	27/04/15
Martin Bengtsson DFI	Director of Finance/CFO	47	03/02/19
Michael Sestrick CTO	Chief Tech/Sci/R&D Officer	61	31/12/16

Manager	Title	Age	Since
David Fischer BRD	Director/Board Member	61	15/09/10
Theodore Harris CEO	Chief Executive Officer	59	27/04/15
Matthew Wineinger BRD	Director/Board Member	57	14/09/15

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
BALCHEM CORPORATION	-0.58%	-2.70%	+26.37%	+20.15%	5.47B
ECOLAB INC.	+1.32%	+0.14%	+35.10%	+9.17%	69.73B
SIKA AG	+1.62%	-3.52%	+8.27%	-18.94%	49.38B
GIVAUDAN SA	+2.00%	+3.43%	+55.98%	-0.88%	48.35B
FUJIFILM HOLDINGS CORPORATION	+1.56%	-1.66%	+31.36%	+20.46%	32.04B
EMS-CHEMIE HOLDING AG	+1.17%	-3.08%	+6.70%	-29.54%	19.04B
SYMRISE AG	+1.39%	+1.77%	+32.29%	-0.41%	18.48B
CELANESE CORPORATION	+0.80%	-3.40%	-3.96%	-20.85%	13.12B
POSCO FUTURE M CO., LTD.	-4.63%	-3.96%	-50.72%	+34.20%	12.56B
NITTO DENKO CORPORATION	-0.62%	-7.26%	+10.80%	+22.92%	11.17B
Average	+0.35%	-4.77%	+15.22%	+3.63%	27.93B
Weighted average by Cap.	+1.01%	-3.44%	+24.58%	+0.97%

	2024 *	2025 *
Net sales	960M 73.41B	1.03B 78.64B
Net income	127M 9.73B	150M 11.49B
Net Debt	129M 9.84B	-26.93M -2.06B